F. Ionică, C. Pisoschi, D. Protasiewicz, M. Moța, D. Lacatis, and F. Popescu, “EFFICIENCY OF ATORVASTATIN THERAPY FOR DECREASING THE LEVEL OF HIGHLY SENSITIVE C- REACTIVE PROTEIN (HSCRP) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, RJDNMD, vol. 17, no. 2, Jun. 2010.